Dr. Sourav De | Medicinal Chemistry | Best Researcher Award

Eminent College of Pharmaceutical Technology, India

Profiles

• Scopus Profile
• ORICD Profile
• Google Scholar

Education and Academic Background

Dr. Sourav De is a distinguished researcher and educator currently affiliated with Eminent College of Pharmaceutical Technology, India. He earned his Doctor of Philosophy (Ph.D.) in Chemistry from the School of Advanced Sciences, Vellore Institute of Technology (VIT), India (March 2017 – December 2020). Under the guidance of Dr. S. K. Ashok Kumar, Professor, his doctoral thesis focused on the design, synthesis, characterization, and anticancer evaluation of various heterocycles and Ru(II)-arene-N^N, N^O, N^S complexes. His strong academic foundation also includes an M.Pharm in Pharmaceutical Chemistry from West Bengal University of Technology (2010–2012), where he graduated with a CGPA of 8.79 (First Class), and a B.Pharm from the University of North Bengal (2006–2010), securing 74% (First Class).

Research Interests

Dr. Sourav De’s research interests span a diverse range of medicinal chemistry and organometallic chemistry, with a strong emphasis on the therapeutic applications of organic and organometallic complexes. His key areas of focus include: Molecular Modeling and In-Silico Studies for drug discovery and computational chemistry. Chromogenic and Fluorogenic Sensors for biomedical and pharmaceutical applications. Cancer Research, particularly in the treatment of cervical, colon, breast, and brain tumors.

Research Projects

Dr. De has actively contributed to multiple academic research and technology development projects, showcasing his expertise in cancer theranostics, drug discovery, and molecular design. Notable projects include: DST-SERB Sponsored Project: He worked as a Project Assistant on the Development of novel 2-aryl benzothiazole/benzoxazole, quinoxaline, and phenanthroline analogues as fluorescent probes and cancer theranostics applications (EMR/2017/000816). Grant-in-Aid SEED Fund Research Project: As a Principal Investigator, he led a research project titled “In silico analysis of some ruthenium complexes as potential anti-cancer agents,” funded by Rs. 85,000 (AU/REG/NOT/2021/04/003). With over 11 years and 9 months of research experience, Dr. De has made impactful contributions to the fields of drug development and computational chemistry.

Technical Skills

Dr. Sourav De possesses strong technical expertise across various analytical instruments, imaging techniques, and computational tools. His skill set includes: Instruments Handled: UV, FL, FTIR, CD spectroscopy, ELISA reader, Gel Doc, and HPLC. Imaging Techniques: Fluorescent Microscopy, Scanning Electron Microscopy (SEM), and Flow Cytometry. Computational and Analytical Tools: Molecular Modeling & Docking: AutoDock 4.2, AutoDock Vina, Chimera 1.11rc, Open Babel GUI. Data Analysis: Python for scientific computing and data visualization. Plotting and Molecular Visualization: Origin, ChemDraw, ChemSketch. Hands-on Experience: Cell culture, molecular biology, and bioinformatics for drug-target interactions and cancer research.

Teaching Experience

Dr. De is an experienced educator specializing in pharmaceutical and medicinal chemistry. He has taught various subjects, including: Pharmaceutical Chemistry & Medicinal Chemistry, Organic and Inorganic Chemistry, Pharmaceutical Analysis & Instrumental Analysis. His teaching methodology combines practical applications and research-driven insights, ensuring students gain both theoretical knowledge and hands-on experience.

Future Research and Contributions

Dr. Sourav De is committed to advancing therapeutic drug design, molecular diagnostics, and cancer research. His future work aims to develop targeted anticancer drugs, bioactive organometallic complexes, and AI-driven molecular modeling techniques. With his expertise in pharmaceutical sciences and computational chemistry, he continues to make significant contributions to drug discovery and medicinal research.

Notable Publications

• Pyridine: the scaffolds with significant clinical diversity

  • Authors: S De, AK SK, SK Shah, S Kazi, N Sarkar, S Banerjee, S Dey
  • Journal: RSC Advances
  • Year: 2022

• Critical role of dipeptidyl peptidase IV: a therapeutic target for diabetes and cancer

  • Authors: S De, S Banerjee, SKA Kumar, P Paira
  • Journal: Mini Reviews in Medicinal Chemistry
  • Year: 2019

• Synthesis, characterisation, molecular docking, biomolecular interaction and cytotoxicity studies of novel ruthenium (II)–arene-2-heteroarylbenzoxazole complexes

  • Authors: S De, SR Chaudhuri, A Panda, GR Jadhav, RS Kumar, P Manohar, …
  • Journal: New Journal of Chemistry
  • Year: 2019

• Amberlite IR-120 (H) mediated “on water” synthesis of fluorescent Ruthenium (II)-arene 8-hydroxyquinoline complexes for cancer therapy and live cell imaging

  • Authors: A Mondal, S De, S Maiti, B Sarkar, AK Sk, R Jacob, A Moorthy, P Paira
  • Journal: Journal of Photochemistry and Photobiology B: Biology
  • Year: 2018

• Luminescent ruthenium (II)-para-cymene complexes of aryl substituted imidazo-1,10-phenanthroline as anticancer agents and the effect of remote substituents on cytotoxic activities

  • Authors: S De, RS Kumar, A Gauthaman, SKA Kumar, P Paira, A Moorthy, …
  • Journal: Inorganica Chimica Acta
  • Year: 2021